{"name":"D2M Biotherapeutics Inc.","slug":"d2m-biotherapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1LUzNIVlhEU0NXMkVhQjc1bGQwa0JodnRXSV9ISkdLQVN0d2l5M3VITm5tbUwxZjlvV2p5LVhqYjEwVjJhSEdjMDF5UUJaZWZhTzJRZy14YWpfUFo3VDJrVnhWZnlnVzlZSmpZU3NoYUxBZw?oc=5","date":"2024-04-19","type":"trial","source":"Clinical Trials Arena","summary":"D2M Biotherapeutics doses first subject in solid tumour treatment trial - Clinical Trials Arena","headline":"D2M Biotherapeutics doses first subject in solid tumour treatment trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQNmhCRTlnWkxNdzFRd0k3WGQtaUo1UjYtNGNoMnBFSzRXUTVLMTFRYm5Dd0pSVC1xVlpxV1NyOFZ6MjFmckUwWVp6Q0ZhSGNfRVJFT3ZOSWZsNWVybW85cXp3eWg4aWJnNXV0eFVSX0xDVWtraV9RTG5lTTViRUZIdVVkd09FbzhPQjdVYUNGekZtNWhPYzM3NWEyM0p3eTF3N2trT01HMA?oc=5","date":"2024-04-18","type":"trial","source":"BioSpace","summary":"D2M Biotherapeutics Announces First Patient Dosed in A Phase 1 Study Evaluating - BioSpace","headline":"D2M Biotherapeutics Announces First Patient Dosed in A Phase 1 Study Evaluating","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPTXZrMkI3Ulh4eTBmLUlZUUhxSGJ1VmRPZThQVFc3YnJuVUlwSk9TR0NSTGNkMVZ4MVowR1hscUZhVGxkYmFlVVBpVE5ZNy1iUDNsMWNvT3ZaczNtNUU2ZEZTTk45N2NwYmYxRkdrRlpOejJIZ21UMlpvcUxpbktkb3BPSFM1MENURTFuMWlpeXVOUHFxSnc?oc=5","date":"2024-04-18","type":"pipeline","source":"BioSpace","summary":"23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer - BioSpace","headline":"23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}